BML Investment Partners, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share (ORMP)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: Leonard Braden Michael
Security: ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share
Symbol: ORMP
Shares outstanding: 39,608,807 shares
Disclosed Ownership: 3,287,531 shares
Ownership: 8.3%
Form type: SCHEDULE 13G/A
Filing time: 09 Feb 2026, 14:13:43 UTC
Date of event: 31 Dec 2025
Previous filing: 13 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	7.9%	3,167,231	0	3,167,231	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Leonard Braden Michael	8.3%	3,287,531	120,300	3,167,231	Braden M Leonard	Leonard Braden Michael